Benign neonatal hemangiomatosis

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Benign neonatal hemangiomatosis | |
|---|---|
| Synonyms | |
| Pronounce | |
| Specialty | Dermatology, Pediatrics |
| Symptoms | Multiple hemangiomas on the skin |
| Complications | N/A |
| Onset | Neonatal period |
| Duration | |
| Types | N/A |
| Causes | |
| Risks | |
| Diagnosis | Clinical diagnosis, Imaging studies |
| Differential diagnosis | Infantile hemangioma, Kasabach-Merritt syndrome |
| Prevention | N/A |
| Treatment | Observation, Propranolol |
| Medication | |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | |
Benign Neonatal Hemangiomatosis is a rare vascular disorder characterized by the presence of multiple hemangiomas on the skin of newborns. Unlike a single hemangioma, which is a common and benign tumor of the blood vessels often referred to as a birthmark, benign neonatal hemangiomatosis involves multiple lesions. These lesions are typically benign and have a tendency to regress spontaneously over time. However, their presence can be a cause for concern due to potential complications and associations with internal organ involvement.
Etiology[edit]
The exact cause of benign neonatal hemangiomatosis remains largely unknown. It is believed to involve a combination of genetic and environmental factors. Some studies suggest a role of angiogenic factors, which are substances that promote the growth of new blood vessels, in the development of these lesions.
Clinical Presentation[edit]
Infants with benign neonatal hemangiomatosis present with multiple, small to large, red to purplish lesions scattered over the body. These hemangiomas are usually present at birth or appear within the first few weeks of life. While the skin is the most common site, internal organs can occasionally be involved. The number of lesions can vary significantly from a few to hundreds.
Diagnosis[edit]
Diagnosis of benign neonatal hemangiomatosis is primarily clinical, based on the characteristic appearance of the lesions. In cases where internal organ involvement is suspected, imaging studies such as ultrasound, MRI, or CT scan may be utilized to assess the extent of the disease.
Treatment[edit]
The treatment of benign neonatal hemangiomatosis is largely conservative, given the high rate of spontaneous regression. Observation is usually recommended for uncomplicated, asymptomatic lesions. For symptomatic lesions, or those causing complications, treatment options may include corticosteroids, laser therapy, or, in rare cases, surgery. The choice of treatment depends on the size, location, and severity of the lesions.
Prognosis[edit]
The prognosis for infants with benign neonatal hemangiomatosis is generally good, with many lesions undergoing spontaneous regression within the first few years of life. However, close monitoring is essential to identify and manage potential complications, such as ulceration, bleeding, or, in rare cases, heart failure due to high-output cardiac demand from large or numerous lesions.
Complications[edit]
While benign neonatal hemangiomatosis is generally a benign condition, complications can occur, especially with large or strategically located hemangiomas. These complications can include ulceration, infection, bleeding, and, in cases of significant internal organ involvement, functional impairment of the affected organ.
Summary[edit]
Benign neonatal hemangiomatosis is a rare but generally benign condition characterized by the presence of multiple hemangiomas in newborns. Despite its benign nature, careful monitoring and appropriate management are crucial to prevent and address potential complications. With the majority of lesions regressing spontaneously, the long-term outlook for affected infants is positive.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

